Company / Return on Equity (ROE)
Fortress Biotech, Inc. Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-92.2%
FY2025
5-year range
-384.0% / -42.8%
FY2021-FY2025
Trend
+65.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Fortress Biotech, Inc. reports negative total equity of -92.2% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-92.2% in FY2025 with a 5-year CAGR of +60.2%.
Improved from -384.0% to -92.2% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +62.8pp
- 5-Year Change
- +60.2pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on equity (roe) increased 65.4% year-over-year.
- Peak return on equity (roe) was recorded in FY2021.
- Lowest return on equity (roe) in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -92.2% | +65.4% |
| FY2024 | -266.7% | +30.6% |
| FY2023 | -384.0% | -147.6% |
| FY2022 | -155.1% | -262.3% |
| FY2021 | -42.8% | +71.9% |
| FY2020 | -152.4% | +52.5% |
| FY2019 | -321.0% | +91.1% |
| FY2018 | -3611.0% | -3819.9% |
| FY2017 | -92.1% | -73.9% |
| FY2016 | -53.0% | +19.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026